Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4301
Smartbird Inc
BIRD
$19.5M
| $62.8K | ﹤0.01% |
1,299
-2,572
| -66% | -$151K |
|
4302
Workhorse Group
WKHS
$33.2M
| $62.3K | ﹤0.01% |
14
+12
| +600% | +$82.7K |
|
4303
Ring Energy
REI
$315M
| $62.3K | ﹤0.01% |
25,314
+20,658
| +444% | +$56.7K |
|
4304
Gold Fields
GFI
$29B
| $62.1K | ﹤0.01% |
6,000
-22,000
| -79% | -$213K |
|
4305
AirSculpt Technologies
AIRS
$339M
| $61.6K | ﹤0.01% |
16,654
+2,799
| +20% | +$13K |
|
4306
Clarus
CLAR
$123M
| $61.6K | ﹤0.01% |
7,856
-14,251
| -64% | -$139K |
|
|
DSKE
4307
DELISTED
Daseke, Inc. Common Stock
DSKE
| $61.6K | ﹤0.01% |
10,820
+8,940
| +476% | +$52.8K |
|
|
INFA
4308
DELISTED
Informatica
INFA
| $61.4K | ﹤0.01% |
3,771
-666
| -15% | -$12K |
|
4309
FVCBankcorp
FVCB
$335M
| $61.2K | ﹤0.01% |
4,010
+3,376
| +532% | +$53.1K |
|
4310
Monte Rosa Therapeutics
GLUE
$1.4B
| $60.8K | ﹤0.01% |
7,988
+6,772
| +557% | +$56.4K |
|
|
YELL
4311
DELISTED
Yellow Corporation Common Stock
YELL
| $60.7K | ﹤0.01% |
24,186
+23,561
| +3,770% | +$83.9K |
|
4312
Janux Therapeutics
JANX
$925M
| $60.7K | ﹤0.01% |
4,608
+3,880
| +533% | +$56.8K |
|
4313
Imperial Petroleum
IMPP
$213M
| $60.7K | ﹤0.01% |
16,771
| – | – |
|
4314
KRONOS Worldwide
KRO
$693M
| $60.6K | ﹤0.01% |
6,449
+5,010
| +348% | +$47.4K |
|
4315
MVB Financial
MVBF
$397M
| $60.6K | ﹤0.01% |
2,750
+2,316
| +534% | +$56.6K |
|
|
HLTH
4316
DELISTED
Cue Health Inc. Common Stock
HLTH
| $60.5K | ﹤0.01% |
29,235
+24,619
| +533% | +$77.8K |
|
4317
GrowGeneration
GRWG
$86.5M
| $60.4K | ﹤0.01% |
15,414
+12,980
| +533% | +$61.9K |
|
|
TEI
4318
Templeton Emerging Markets Income Fund
TEI
$314M
| $60.2K | ﹤0.01% |
10,532
| – | – |
|
4319
Red Violet
RDVT
$979M
| $60.2K | ﹤0.01% |
2,613
+2,206
| +542% | +$44.9K |
|
|
DZSI
4320
DELISTED
DZS Inc. Common Stock
DZSI
| $60K | ﹤0.01% |
4,730
+3,872
| +451% | +$49.2K |
|
4321
Red River Bancshares
RRBI
$662M
| $59.8K | ﹤0.01% |
1,172
+972
| +486% | +$53K |
|
|
NETI
4322
DELISTED
Eneti Inc.
NETI
| $59.8K | ﹤0.01% |
5,946
+4,951
| +498% | +$43.9K |
|
|
SCU
4323
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $59.7K | ﹤0.01% |
6,889
+5,666
| +463% | +$54.3K |
|
|
LAZR
4324
PUT
DELISTED
Luminar Technologies
LAZR
| $59.4K | ﹤0.01% |
+800
| New | +$87.1K |
|
4325
Invesco NASDAQ Internet ETF
PNQI
$528M
| $59.4K | ﹤0.01% |
2,645
| – | – |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 798 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.